Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Healthtrust
Argus Health
Colorcon
Accenture
Moodys
Dow
Fuji
Cerilliant

Generated: January 23, 2019

DrugPatentWatch Database Preview

Jubilant Generics Company Profile

« Back to Dashboard

What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?

JUBILANT GENERICS has thirty-nine approved drugs.



Summary for Jubilant Generics
US Patents:0
Tradenames:35
Ingredients:34
NDAs:39
Patent Litigation for Jubilant Generics: See patent lawsuits for Jubilant Generics

Drugs and US Patents for Jubilant Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 203983-001 Aug 19, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Generics OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 205482-001 Apr 24, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Generics RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 090839-004 Nov 4, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Generics LEVOFLOXACIN levofloxacin TABLET;ORAL 203613-001 Jun 19, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Chubb
Queensland Health
Farmers Insurance
US Department of Justice
Accenture
UBS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.